AI-generated summary
In this randomized clinical trial of 20 patients undergoing crown lengthening surgery, one tooth per patient received 808 nm and 660 nm diode laser photobiomodulation while the other served as an untreated control. The authors report that photobiomodulation was associated with better clinical signs of inflammation on day 7, better clinical signs of homeostasis on days 3 and 7, and lower postoperative pain, with no significant difference in re-epithelialization.
- Participants
- 20
- Who or what was studied
- Patients who underwent surgical crown lengthening on both sides of the jaw, with one tooth per patient randomly assigned to treatment or control
- Wavelengths
- 808, 660 nm
- Limits stated in the abstract
- The abstract reports a small sample of 20 patients and does not describe the magnitude of the effects or the certainty of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The present study evaluated the synergistic effect of 808 nm and 660 nm diode lasers on the processes of healing and pain management following crown lengthening surgery.
Methods
This randomized clinical trial involved 20 patients who underwent surgical crown lengthening on both sides of their jaw. Following the surgery, one tooth from each patient was randomly assigned to either the case group (irradiated with 808 nm and 660 nm diode lasers as photobiomodulation [PBM] therapy) or the control group (laser device remained switched off). The early healing index (EHI), comprising clinical signs of inflammation (CSI), clinical signs of homeostasis (CSH), and clinical signs of re-epithelialization (CSR), was assessed on days 3 and 7. Pain severity was quantified on the day of surgery and 1, 3, and 7 days after surgery using a visual analog scale. The data were analyzed using the Wilcoxon test.
Results
No significant differences were observed in CSR on days 3 (P=0.18) and 7 (P=1.0), nor in CSI on day 3 (P=0.477) after surgery. However, a significant difference was identified in CSI on day 7 and in CSH on both days 3 and 7 (P<0.05) after surgery. Furthermore, the level of postoperative pain demonstrated a significant difference (P≤0.005).
Conclusion
PBM demonstrably enhanced CSI by day 7 and improved CSH by days 3 and 7, in addition to decreasing postoperative pain.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm, 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Wound healing, Control group, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.